NuVasive to Participate in 42nd Annual Cowen Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street dips after strong jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil slides on Friday, heads for weekly gain on US-Iran fight
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Credit Suisse Positive on NuVasive (NUVA), 'Momentum Improving, Driven by Critical Mass of New Products and Growth Drivers', Street High PT $75
February 24, 2022 2:15 PM ESTCredit Suisse analyst Matt Miksic lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $83.00) while maintaining a Outperform rating.
The analyst comments "Spine Momentum Results in a Better-Than-Expected Finish, Despite COVID and Staffing Challenges: Mgmts strategy combining new and innovative product launches and enabling technology showed solid results in terms of... More
